Back to News
Market Impact: 0.15
ONWARD Medical Marks First Implant In EIGER Study Of ARC-IM System
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsTechnology & Innovation
Onward Medical announced the first implant in its EIGER clinical feasibility study of the investigational ARC-IM System for restoring mobility in people with subacute (chronic) spinal cord injury. This milestone advances the study’s start/activation, supporting incremental clinical progress for the program.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
More News
- Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
- Bessent proposes U.S.-China AI safety system in talks with China
- Here are the 3 big things we're watching in the stock market this week
- Tech leads shares higher in Asia, oil eases
- China slows humanoid robot IPO rush as hype outruns reality
- Société Générale présente une feuille de route stratégique ambitieuse portée par une exécution disciplinée